Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet

Summary

Study to evaluate patient preference of deferasirox film-coated tablet (FCT) or deferasirox dispersible tablet (DT) in patient with transfusion - dependent thalassemia or non-transfusion -dependent thalassemia as measured by preference questionnaire at Week 48

Timeline

Start

2017-07-27

Primary completion

2020-01-29

Completion

2021-03-11

Outcome

Met primary endpoint

registry analysis (superiority test); Deferasirox DT Followed By Deferasirox FCT; p <.0001; Difference of proportion 0.83 (95% CI 0.75 to 0.89); McNemar NCT02993224 ↗

Drugs

Indications